article · BMC Cardiovascular Disorders
Programmes preventing mother-to-child HIV transmission have increased the number of infants who are exposed to HIV and antiretroviral treatments in the womb but remain uninfected. A study in North-Central Nigeria assessed cardiac structure and function in 156 HIV-exposed uninfected infants alongside 156 unexposed infants aged up to 52 weeks using transthoracic echocardiography. Echocardiographic cardiac abnormalities were present in 66.7 percent of the exposed infants compared to only 2.6 percent of the unexposed group. The affected infants showed thicker heart walls and higher contractile measures, though overt structural lesions remained rare across both cohorts. Poorer maternal health, specifically lower CD4 counts and higher viral loads, was strongly linked to increased odds of these heart changes, whereas multiparity was associated with lower odds. These predominantly subclinical cardiac changes highlight a need for longer-term monitoring of this growing paediatric population.
As prevention programmes successfully protect infants from contracting HIV, attention must turn to secondary health impacts from maternal disease and antiretroviral therapy. Understanding early heart changes in uninfected infants helps healthcare systems recognise subtle paediatric cardiovascular risks linked to maternal immune status and identify which infants might require closer clinical observation.
This early-stage observational research does not describe a commercial product or service, but it could eventually inform paediatric clinical screening protocols and cardiovascular diagnostic guidelines once longitudinal data confirm clinical relevance. The abstract does not indicate an immediate application pathway or commercialisation opportunity.
AI-generated from the published abstract. Always read the original work before citing.
The successful scale-up of prevention of mother-to-child transmission (PMTCT) programmes has led to a rapidly growing population of HIV-exposed uninfected (HEU) infants worldwide. Although these infants remain HIV-negative, emerging evidence suggests that in-utero exposure to maternal HIV infection and antiretroviral therapy may influence cardiovascular development. However, data on echocardiographic cardiac abnormalities among HEU infants in sub-Saharan Africa, particularly Nigeria, remain limited. A comparative cross-sectional study was conducted among 312 infants, comprising 156 HEU and 156 HIV-unexposed infants aged 0–52 weeks attending the Federal Medical Centre, Bida, North-Central Nigeria.Standard transthoracic echocardiography was performed to assess cardiac structure and function. Measurements were evaluated against both Nigerian and Detroit paediatric reference values, while cardiac abnormalities were classified using Detroit reference standards. Echocardiographic parameters were compared between groups using independent-samples t-tests and Pearson's χ² or Fisher’s exact tests, as appropriate. Factors associated with echocardiographic cardiac abnormalities were identified using bivariable and multivariable logistic regression analyses in the HEU group. Echocardiographic cardiac abnormalities were more prevalent among HEU infants than HIV-unexposed infants (66.7% vs. 2.6%; p < 0.001). Compared with HIV-unexposed infants, HEU infants had greater interventricular septal and left ventricular posterior wall thicknesses, as well as higher fractional shortening and ejection fraction values. Structural cardiac lesions were uncommon in both groups. Among HEU infants, maternal CD4 count < 500 cells/mm³ (aOR 3.29, 95% CI 1.51–7.18; p = 0.003) and maternal viral load ≥ 200 copies/mL (aOR 3.07, 95% CI 1.30–7.25; p = 0.011) were independently associated with increased odds of echocardiographic cardiac abnormalities, whereas multiparity was independently associated with reduced odds (aOR 0.22, 95% CI 0.06–0.84; p = 0.027). HEU infants demonstrated a substantially higher burden of predominantly subclinical echocardiographic cardiac abnormalities than HIV-unexposed infants. Poor maternal immunological and virological status was independently associated with these abnormalities. Longitudinal studies are needed to determine their persistence and long-term clinical significance before routine echocardiographic screening of HEU infants can be recommended.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1186/s12872-026-06558-2
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
